To date, 12 miRNAs have been reported to target TRIAP1, including miR‐18a in epithelial ovarian cancer,380 miR‐107 in BrC,379 gastric cancer (GC),43 NSCLC,386 and OSCC,374 miR‐125a‐5p in HCC373 and thyroid cancer (TC),375 miR‐137 in osteosarcoma (SaOS),376 miR‐203 in PCa,382 miR‐320b in nasopharyngeal carcinoma (NPC),385 miR‐506 in PCa,381 miR‐539 in SaOS,370 and miR‐1301 in SaOS,377 and miR‐125b‐5p,389 miR‐320d,390 and miR‐770‐5p391, 392 in noncancerous disease. Here, TRIAP1 is linked to posterior cortical atrophy.